4.3 Article

microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression

Journal

ONCOTARGET
Volume 5, Issue 9, Pages 2792-2806

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.1920

Keywords

hepatocellular carcinoma; USP4; S1P1; miR-148a; migration; growth

Funding

  1. National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2007-0056817]
  2. National Cancer Control grant from the Ministry of Health and Welfare of South Korea [11200203-20982]
  3. National Cancer Center, Korea [1110050]
  4. Korea Health Promotion Institute [1110050] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Hepatocellular carcinoma (HCC) is classified as a poor prognostic tumor, and becomes frequently aggressive. MicroRNAs emerge as key contributors to tumor progression. This study investigated whether miR-148a dysregulation differentiates poor prognosis of HCC, exploring new targets of miR-148a. miR-148a dysregulation discriminated not only the overall survival and recurrence free survival rates of HCC, but the microvascular invasion. In the human HCC samples, ubiquitin specific protease 4 (USP4) and sphingosine 1-phosphate receptor 1 (S1P1) were up-regulated as the new targets of miR-148a. USP4 and S1P1 were up-regulated in mesenchymal-type liver-tumor cells with miR-148a dysregulation, facilitating migration and proliferation of tumor cells. The inverse relationship between miR-148a and the identified targets was verified in a tumor xenograft model. In the analysis of human samples, the expression of USP4, but not S1P1, correlated with the decrease of miR-148a. In a heterotropic patient-derived HCC xenograft model, USP4 was also overexpressed in G1 and G2 tumors when miR-148a was dysregulated, reflecting the closer link between miR-148a and USP4 for a shift in the expansion phase of tumorgraft. In conclusion, miR-148a dysregulation affects the poor prognosis of HCC. Of the identified targets of miR-148a, USP4 overexpression may contribute to HCC progression towards more aggressive feature.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Gastroenterology & Hepatology

Integrated prognostic and histogenomic justification of stage-directed therapy for single large hepatocellular carcinoma: a Korean nationwide registry study

Jihyun An, Ha Il Kim, Bora Oh, Yoo-Jin Oh, Ji-Hye Oh, Wonkyung Kim, Chang Ohk Sung, Ju Hyun Shim

Article Gastroenterology & Hepatology

Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas

Jihyun An, Deokhoon Kim, Bora Oh, Yoo-Jin Oh, Jihyun Song, Naomi Park, Ha Il Kim, Hyo Jeong Kang, Ji-Hye Oh, Wonkyung Kim, Eunjung Lee, Chang Ohk Sung, Gi-Won Song, Dae-Ghon Kim, Eunsil Yu, Eric Letouze, Jessica Zucman-Rossi, Han Chu Lee, Ju Hyun Shim

Summary: This study identified the landscape and mechanisms of HBV integration in iCCA tumors, revealing recurrent viral integration breakpoints at multiple sites including TERT and FAT2, and oncogenic effects through intergenic insertions activating the mTOR pathway. The mutational profiles of HBV-iCCA were found to be more similar to nonviral conventional iCCA, rather than HBV-related liver cancers like HBV-HCC and HBV-cHCC/CCA.

HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury

Ayoung Kim, Ja Hyun Koo, Jung Min Lee, Min Sung Joo, Tae Hyun Kim, Hyunsung Kim, Dae Won Jun, Sang Geon Kim

Summary: This study investigated the role of NRF2-mediated SIRT3 activation in ER stress. The results showed that NRF2 induced SIRT3 through antioxidant responsive elements, protecting hepatocytes from ER stress-induced injury.

FASEB JOURNAL (2022)

Review Biochemistry & Molecular Biology

Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease

Yoon Mee Yang, Ye Eun Cho, Seonghwan Hwang

Summary: Alcoholic liver disease (ALD), caused by excessive alcohol consumption, results in liver damage. Studies have shown that there is a relationship between hepatic oxidative stress and inflammatory responses, which may be useful for developing therapeutic approaches for ALD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients

Chung-Feng Huang, Tyng-Yuan Jang, Dae Won Jun, Sang Bong Ahn, Jihyun An, Masaru Enomoto, Hirokazu Takahashi, Eiichi Ogawa, Eileen Yoon, Soung Won Jeong, Jae-Jun Shim, Jae Yoon Jeong, Sung Eun Kim, Hyunwoo Oh, Hyoung Su Kim, Yong Kyun Cho, Ritsuzo Kozuka, Kaori Inoue, Ka Shing Cheung, Lung Yi Mak, Jee-Fu Huang, Chia-Yen Dai, Man-Fung Yuen, Mindie H. Nguyen, Ming-Lung Yu

Summary: The study found that in CHB patients, measuring serum GGT levels during treatment, particularly in non-cirrhotic patients, can effectively predict the development of HCC. Factors strongly associated with increased risk of HCC included high M6-GGT levels, age, gender, and cirrhosis.

LIVER INTERNATIONAL (2022)

Article Gastroenterology & Hepatology

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Summary: Compared to the general population, patients with liver cirrhosis have a lower prevalence of intracranial atherosclerosis, while the prevalence of extracranial atherosclerosis is similar. Thrombocytopenia and high coronary artery calcium score may be associated with intracranial atherosclerosis.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Ju Hyun Shim

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Efficacy and safety of direct-acting antiviral therapy for hepatitis C virus in elderly patients (>= 65 years old): A systematic review and meta-analysis

Jieun Lee, Sang Bong Ahn, Sun Young Yim, Jihyun An, Dae Won Jun, Min Jung Ko, Dong Ah Park, Jeong-Ju Yoo

Summary: This meta-analysis evaluated the efficacy and safety of direct-acting agents (DAAs) in elderly patients. The study found that DAAs had high efficacy in elderly patients, with a notable sustained virologic response (SVR) rate of 96%, although adverse event (AE) rates were comparatively higher in the elderly population.

JOURNAL OF VIRAL HEPATITIS (2022)

Article Gastroenterology & Hepatology

KASL clinical practice guidelines for management of chronic hepatitis B

Jeong Won Jang, Jun Yong Park, Jung Hyun Kwon, Su Jong Yu, Wonseok Kang, Young Eun Chon, Tae Hyung Kim, Jonggi Choi, Jihyun An

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000-Korean outcome study

Jihye Lim, Jung-Bok Lee, Jihyun An, Gi-Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim

Summary: This study provides evidence that prolonged nucleos(t)ide analogues (NAs) treatment for chronic hepatitis B patients may increase the risks of colorectal/anal cancers and lymphoma, but has a protective effect on breast and prostate cancers. The study also shows that NAs do not affect most extrahepatic organs.

JOURNAL OF VIRAL HEPATITIS (2022)

Article Biochemistry & Molecular Biology

Identification of Small GTPases That Phosphorylate IRF3 through TBK1 Activation Using an Active Mutant Library Screen

Jae-Hyun Yu, Eun-Yi Moon, Jiyoon Kim, Ja Hyun Koo

Summary: Multiple small GTPases have been found to promote IRF3 phosphorylation, suggesting their significant contribution in IRF3 signaling and providing a new therapeutic approach against diseases with GTPase overexpression or active mutations.

BIOMOLECULES & THERAPEUTICS (2023)

Article Multidisciplinary Sciences

Nuclear factor (erythroid-derived 2)-like 2 counter-regulates thymosin beta-4 expression and primary cilium formation for HeLa cervical cancer cell survival

Jae-Wook Lee, Pham Xuan Thuy, Ja Hyun Koo, Eun-Yi Moon

Summary: The function of TB4 expression and PC formation in cervical cancer cell survival under conditions of serum deprivation was investigated. It was found that Nrf2 counter-regulates TB4 expression and PC formation, and that H2O2 treatment increases PC formation, which is attenuated in response to TB4 siRNA.

SCIENTIFIC REPORTS (2022)

Article Biochemistry & Molecular Biology

Identification of the primary ciliary proteins IFT38 and IFT144 to enhance serum-mediated YAP activation and cell proliferation

Jae-Hyun Yu, Jeong Heon Kim, Nak-Kyun Soung, Eun-Yi Moon, Ja Hyun Koo

Summary: This study reveals the involvement of ciliary proteins in mitogen signaling and identifies the regulatory roles of IFT38 and IFT144 in serum-mediated Hippo pathway signaling and cellular growth.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

ERdj5 protects goblet cells from endoplasmic reticulum stress-mediated apoptosis under inflammatory conditions

Hyunjin Jeong, Eun-Hye Hong, Jae-Hee Ahn, Jaewon Cho, Jae-Hyeon Jeong, Chae-Won Kim, Byung-Il Yoon, Ja Hyun Koo, Yun-Yong Park, Yoon Mee Yang, Takao Iwawaki, Bruce A. Vallance, Sun-Young Chang, Hyun-Jeong Ko

Summary: A study on inflammatory bowel disease reveals that an enzyme can protect intestinal goblet cells from cell death during gut inflammation. Modifying the molecular mechanisms of this enzyme could potentially prevent and treat inflammatory bowel disease.

EXPERIMENTAL AND MOLECULAR MEDICINE (2023)

Article Gastroenterology & Hepatology

Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology: A network meta-analysis of randomized sorafenib-controlled trials

Jihyun An, Seungbong Han, Ha Il Kim, Ju Hyun Shim

Summary: This study compared different treatment options for advanced hepatocellular carcinoma and found that atezolizumab+bevacizumab was the best first-line systemic modality, especially for patients with portal invasion.

HEPATOLOGY COMMUNICATIONS (2022)

No Data Available